IMMUNOGLOBULIN HUMAN ANTITETANUS, 250 IU/ml, syr.

STD DVACIMTE2S-

Valid Article

Former Code(s): -X DVACATET2S-
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
11.2.1 - Human immunoglobulins
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J06BB02
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

IMMUNOGLOBULIN HUMAN ANTITETANUS

Therapeutic Action

Human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against the toxin produced by the bacteria Clostridium tetani.

Indications

Prevention of tetanus in wound management, in patients non immunised or incompletely immunised or in patients whose immunisation status is unknown.

Treatment of clinical tetanus

Instructions for use

Must be given by IM route only.

Do not administer by IV route.

Precautions for Use

As with all injectable vaccines and/or immunoglobulins, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the product.

Storage

  • Keep refrigerated between 2ºC and 8ºC - Protect from sunlight
  • Do not freeze.

(Cf Introduction: Thermosensitive products)